Financials Seyitler Kimya Sanayi

Equities

SEYKM

TRESEYT00011

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Istanbul 11:09:58 2024-05-03 am EDT 5-day change 1st Jan Change
11.11 TRY +10.00% Intraday chart for Seyitler Kimya Sanayi +26.25% +95.25%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 82.53 61.6 108.6 552 410.8 676.1
Enterprise Value (EV) 1 78.82 60.79 103.2 536.9 377.9 613.1
P/E ratio 44 x 23.4 x 22.6 x 27.3 x 30.4 x 9.47 x
Yield - - - - - -
Capitalization / Revenue 4.84 x 2.57 x 3.29 x 10.4 x 6.82 x 6.09 x
EV / Revenue 4.62 x 2.53 x 3.12 x 10.1 x 6.28 x 5.52 x
EV / EBITDA 32.6 x 17.3 x 21.6 x 54.4 x 37.7 x 20 x
EV / FCF -44.5 x -105 x 107 x -68.5 x -241 x -21 x
FCF Yield -2.25% -0.95% 0.94% -1.46% -0.41% -4.77%
Price to Book 4.08 x 2.7 x 3.93 x 11.5 x 5.69 x 4.71 x
Nbr of stocks (in thousands) 100,001 100,001 100,000 100,000 100,000 100,000
Reference price 2 0.8253 0.6160 1.086 5.520 4.108 6.761
Announcement Date 2/18/18 2/28/19 2/20/20 2/23/21 2/28/22 2/24/23
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 17.04 24.01 33.04 52.9 60.19 111
EBITDA 1 2.415 3.505 4.785 9.871 10.03 30.6
EBIT 1 1.84 2.628 3.987 8.757 8.399 28.62
Operating Margin 10.79% 10.94% 12.07% 16.55% 13.95% 25.78%
Earnings before Tax (EBT) 1 2.172 3.388 5.652 20.25 24.53 79.35
Net income 1 1.874 2.63 4.805 20.2 24.34 71.43
Net margin 11% 10.95% 14.54% 38.18% 40.43% 64.36%
EPS 2 0.0187 0.0263 0.0480 0.2020 0.1353 0.7143
Free Cash Flow 1 -1.773 -0.577 0.9688 -7.833 -1.567 -29.26
FCF margin -10.4% -2.4% 2.93% -14.81% -2.6% -26.36%
FCF Conversion (EBITDA) - - 20.25% - - -
FCF Conversion (Net income) - - 20.16% - - -
Dividend per Share - - - - - -
Announcement Date 2/18/18 2/28/19 2/20/20 2/23/21 2/28/22 2/24/23
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 3.71 0.81 5.46 15.1 32.9 63
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.77 -0.58 0.97 -7.83 -1.57 -29.3
ROE (net income / shareholders' equity) 10.1% 12.2% 19% 53.5% 40.5% 66.2%
ROA (Net income/ Total Assets) 4.99% 6.71% 7.87% 10% 6.3% 12.2%
Assets 1 37.55 39.21 61.05 201.1 386.3 586.7
Book Value Per Share 2 0.2000 0.2300 0.2800 0.4800 0.7200 1.440
Cash Flow per Share 2 0.0400 0.0100 0.0200 0.0500 0.1800 0.3300
Capex 1 0.75 0.48 1.89 5.62 5.41 2.87
Capex / Sales 4.41% 2% 5.72% 10.62% 8.99% 2.59%
Announcement Date 2/18/18 2/28/19 2/20/20 2/23/21 2/28/22 2/24/23
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SEYKM Stock
  4. Financials Seyitler Kimya Sanayi